Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD
Go back to Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD| UNITED STATES BRENT OIL FUND, LP (NYSE: BNO) | Delayed: 50.64 +0.90 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.74 | 52 Week High | $15.92 | |||
| Open | $49.76 | 52 Week Low | $8.80 | |||
| Day High | $50.75 | P/E | N/A | |||
| Day Low | $49.49 | EPS | $0.00 | |||
| Volume | 870,661 | |||||
| (AMEX: BNOEF) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.37 | |||
| Open | $20.67 | 52 Week Low | $0.20 | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $0.00 | |||
| Volume | 6,198 | |||||
